Vaizian™ is a medical software company that is focused on improving the process of diagnosing and treating patients with chest pain in the health care industry. The company's slogan, "Vaizian is a medical software company that helps ER doctors rapidly diagnose and treat patients with chest pain," encapsulates its mission. The software developed by Vaizian incorporates artificial intelligence with clinical assessment and specialist expertise to assist doctors in avoiding biased misdiagnosis and providing accurate and efficient patient outcomes at minimal cost. Founded by a team from the University of Chicago's Medical Center and the Booth School of Business in 2019, Vaizian aims to revolutionize the diagnosis accuracy of the medical field. The company's innovative approach provides doctors and patients with an accurate analysis of symptoms using advanced artificial intelligence technology, ultimately aimed at maximizing real-time care and feedback. Although details regarding the last investment and investors are not currently available, Vaizian's focus on leveraging technology to improve healthcare outcomes positions it as an intriguing prospect for venture capital investment.
There is no investment information
No recent news or press coverage available for Vaizian™.